FRAMEWORK FOR PHARMACOEPIDEMIOLOGY STUDIES

PRESENTATIONS

• Abbing-Karahagopian et al, Timing of Concomitant Drug Use in Pharmacoepidemiological Studies; 28th ICPE, 23-26 Aug 2012, Barcelona

• Afonso A, Comparison of four electronic healthcare databases in Europe using standardized protocols a descriptive study on the incidence of cancer, ICPE Aug 2013

 

• Abbing-Karahagopian V.– Bridging Differences in Findings from Observational Pharmacoepidemiological Studies: The Design and Rationale of Work Package 2 of the PROTECT Project –   27^th ICPE, Chicago, 14-17 August 2011 and Curr. Clin. Pharmacol 2014 May; 9(2): 130-8 http://www.ncbi.nlm.nih.gov/pubmed/24218995

 

• Ballarin et al, A proposed checklist to interpret cross-national comparison studies of drug utilization; 28th ICPE, 23-26 Aug 2012, Barcelona

 

• Belitser S.- Measuring balance and model selection in propensity score methods - 27th ICPE, Chicago, 14-17 August 2011, Pharmacoepidemiology and Drug Safety,20:S1–S364.doi: 10.1002/pds.2206. http://onlinelibrary.wiley.com/doi/10.1002/pds.2206/full

 

• De Groot et al,  Antiepileptic drug AED use in seven electronic health record databases, ICPE Aug 2013

 

• De Groot M. et al, Comparison of seven healthcare databases in EU countries using a standardized, ICPE, Aug 2013

 

• Edwards I.R.et al, Risk identification in Healthcare Records comparison to epidemiological studies, ICPE Aug 2013

 

• Ferrer et al, Inpatient drug consumption in Europe (PROTECT project); 28th ICPE, 23-26 Aug 2012, Barcelona

 

• Gardarsdottir H, Use of antidepressants or benzodiazepines and risk of hipfemur fracture, ICPE Aug 2013

 

• Goldenberg J. – Potential population impact of antidepressant use on hip fractures rate in Denmark, Norway and the Netherlands– 27^th ICPE, Chicago, 14-17 August 2011, Pharmacoepidemiology and Drug Safety, 20: S1–S364.  doi:10.1002/pds.2206.  http://onlinelibrary.wiley.com/doi/10.1002/pds.2206/full

 

• Groenwold R.– Balance measures for propensity score methods: a clinical example on beta-agonist use and the risk of myocardial infarction – 27^th ICPE, Chicago, 14-17 August 2011, Pharmacoepidemiology and Drug Safety, 20: S1–S364. doi:10.1002/pds.2206. http://onlinelibrary.wiley.com/doi/10.1002/pds.2206/full

 

• Groenwold R, Propensity scores and instrumental variables, ISPE Mid-Year Meeting, Munich 11-12 April, 2013

 

• Hesse et al, Calcium Channel Blocker (CCB) Treatments and Cancer Risk. Linking Danish National Health Care databases; 28th ICPE, 23-26 Aug 2012, Barcelona

 

• Ibanez L, Access to reliable Drug Consumption data, ISPE Mid-Year Meeting, Munich 11-12 April, 2013

 

• Ibanez L.- Research activities within PROTECT, Meeting at 2^nd University, Department of Experimental Medicine, Section Pharmacology in Naples, 22 December 2011

 

• Ibanez L.- Research Working Groups on Drug Utilization Across Europe- 26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Brighton, UK, 19-22 August 2010, Pharmacoepidemiology and Drug Safety, 19: S1–S347. doi: 10.1002/pds.2019, http://onlinelibrary.wiley.com/doi/10.1002/pds.2019/full

 

• Juhaeri J, The risk of acute liver injury (ALI) associated with the use of antibiotics, ICPE Aug 2013

 

• Klungel et al, Explaining differences in drug-adverse event associations across and within EU databases. The PROTECT project; 28th ICPE, 23-26 Aug 2012, Barcelona

 

• Klungel O.- Improved control for confounding using propensity scores and instrumental variables? - 2nd Bordeaux Pharmacoepi Festival. 23-25 May 2011

       

• Khong P.– Potential impact of benzodiazepine use on the rate of hip fractures in Denmark, the Netherlands and Norway– 27^th ICPE, Chicago, 14-17 August 2011, Pharmacoepidemiology and Drug Safety, 20: S1–S364. doi: 10.1002/pds.2206. http://onlinelibrary.wiley.com/doi/10.1002/pds.2206/full

 

• Klungel et al, Transparent, Reproducible and Reusable Research in Pharmacoepidemiology, 28th ICPE, 23-26 Aug 2012, Barcelona    

• Primatesta P, Experience in Using the BRAT, Benefit Risk Action Team, Framework Example from PROTECT, ICPE Aug 2013.

• Reynolds R, An Innovative Public-Private Partnership for New Methodologies in Pharmacovigilance and Pharmacoepidemiology, ICPE Aug 2013

• Rottenkolber M, PROTECT –  ein europäisches Projekt zur Durchführung pharmakoepidemiologischer Studien mit Sekundärdaten, 7th German Pharmacovigilance Day (BfArM), Bonn,  15 Nov 2012

• Sabate et al, Antibiotic consumption in 8 European countries: analyses from data provided by IMS Health, 28th ICPE, 23-26 Aug 2012, Barcelona

   

• Sabaté M. – Finding databases on Drug Utilization Information across Europe. What kind of data do they provide?– 27^th ICPE,Chicago, 14-17 August 2011, Pharmacoepidemiology and Drug Safety, 20: S1–S364. doi: 10.1002/pds.2206. http://onlinelibrary.wiley.com/doi/10.1002/pds.2206/full

 

• Sanni Ali et al, Evaluating propensity score balance measures in typical pharmacoepidemiological settings, 28th ICPE, 23-26 Aug 2012, Barcelona

 

• Sanni Ali et al, Time-dependent Propensity Score and Collider-Stratification Bias: an example of beta2-agonist use and risk of myocardial infarction, 28th ICPE, 23-26 Aug 2012, Barcelona

 

• Santander E.- Antiepileptic drug consumption in Catalonia, Norway and Denmark: 2007-2009; XXIV Congress of the Spanish Society of Clinical Pharmacology (Malaga, 5-7 Oct 2011) and EuroDURG Drug Utilisation and Health Policy meeting (Antwerp, 30 Nov-3 Dec 2011)

 

• Schlienger R, de Groot M,Comparative analyses of DrugAdverse Event Associations in Various European Databases; ISPE Mid-Year Meeting, Munich 11-12 April, 2013

• Uddin et al, Application of Instrumental Variables Method in Pharmacoepidemiology an Example of Beta2-Agonist Use and Myocardial Infarction, ICPE Aug 2013.

• Uddin M.J., Performance of Instrumental Variable Methods in Case-Control and Cohort Studies: A Simulation Study, Annual conference on Epidemiology (WEON) in the Rotterdam, Netherlands 14-15 June 2012 and 28th ICPE, 23-26 Aug 2012, Barcelona                                                                        

Back to Results

---